UBS lowered the firm’s price target on QuidelOrtho (QDEL) to $17 from $30 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL:
- QuidelOrtho Announces Chief Legal Officer Leadership Transition
- QuidelOrtho names Nathaniel Sisitsky as Chief Legal Officer
- Rising helium prices could create headwind for Bruker, says Jefferies
- Quidelortho Faces Material Risk from Weak Internal Controls and Sarbanes–Oxley Compliance Challenges
- QuidelOrtho Earnings Call: Growth, Margins And Risks